The IFITM Proteins Inhibit HIV-1 Infection

被引:334
|
作者
Lu, Jennifer [1 ,2 ]
Pan, Qinghua [1 ]
Rong, Liwei [1 ]
Liu, Shan-Lu [3 ,4 ]
Liang, Chen [1 ,2 ,3 ]
机构
[1] McGill Univ, Jewish Gen Hosp, McGill AIDS Ctr, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Med, Montreal, PQ H3A 2B4, Canada
[3] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada
[4] Univ Missouri, Dept Mol Microbiol & Immunol, Bond Life Sci Ctr, Columbia, MO 65211 USA
基金
加拿大健康研究院;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; STABLE SIGNAL PEPTIDE; WEST NILE VIRUS; INTERFERON-ALPHA; T-CELLS; IFN-ALPHA; ENVELOPE GLYCOPROTEIN; DISTINCT MECHANISMS; REPLICATION INVITRO; ANTIVIRAL RESPONSE;
D O I
10.1128/JVI.01531-10
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Type I interferon protects cells from virus infection through the induction of a group of genes collectively named interferon-stimulated genes (ISGs). In this study, we utilized short hairpin RNA (shRNA) to deplete ISGs in SupT1 cells in order to identify ISGs that suppress the production of human immunodeficiency virus type 1 (HIV-1). Among the ISG candidates thus identified were interferon-induced transmembrane (IFITM) proteins, including IFITM1, IFITM2, and IFITM3, that potently inhibit HIV-1 replication at least partially through interfering with virus entry. Further mutagenesis analysis shows that the intracellular region, rather than the N- and C-terminal extracellular domains, is essential for the antiviral activity of IFITM1. Altogether, these data suggest that the IFITM proteins serve as important components of the innate immune system to restrict HIV-1 infection.
引用
收藏
页码:2126 / 2137
页数:12
相关论文
共 50 条
  • [21] Microbicide Containing Ellagic Acid Can Inhibit HIV-1 Infection
    Nittayananta, Wipawee
    Promsong, Aornrutai
    Levy, Claire
    Hladik, Florian
    Chaitaveep, Nithinart
    Ungphaiboon, Suwipa
    Tewtrakul, Supinya
    Satthakarn, Surada
    MOLECULES, 2022, 27 (22):
  • [22] HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection
    Lederle, A.
    Penichon, J.
    Decoville, T.
    Schmidt, S.
    Moog, C.
    Holl, V.
    RETROVIROLOGY, 2009, 6
  • [23] Targeting CCR5 trafficking to inhibit HIV-1 infection
    Boncompain, Gaelle
    Herit, Floriane
    Tessier, Sarah
    Lescure, Aurianne
    Del Nery, Elaine
    Gestraud, Pierre
    Staropoli, Isabelle
    Fukata, Yuko
    Fukata, Masaki
    Brelot, Anne
    Niedergang, Florence
    Perez, Franck
    SCIENCE ADVANCES, 2019, 5 (10):
  • [24] HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection
    Lederle, A.
    Penichon, J.
    Decoville, T.
    Schmidt, S.
    Holl, V.
    Moog, C.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : A51 - A52
  • [25] Proteins identified that may be essential for HIV-1 infection and survival
    Wilson, Hannah
    FUTURE VIROLOGY, 2013, 8 (04) : 328 - 328
  • [26] ELEVATION OF SALIVARY ANTIMICROBIAL PROTEINS FOLLOWING HIV-1 INFECTION
    ATKINSON, JC
    YEH, CK
    OPPENHEIM, FG
    BERMUDEZ, D
    BAUM, BJ
    FOX, PC
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1990, 3 (01): : 41 - 48
  • [27] DING proteins, their biochemical and structural properties, and their ability to inhibit HIV-1 replication
    Chabriere, Eric
    Elias, Mikael
    Hiblot, Julien
    Djeghader, Ahmed
    Schwartz, Christian
    Rohr, Olivier
    Masson, Patrick
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2012, 196 (03): : 693 - 703
  • [28] HIV infection and the risk of cancer: tumorigenicity of HIV-1 auxiliary proteins Comment
    Mowla, Shaheen
    Ahmed, Riyaadh
    FUTURE VIROLOGY, 2022, 17 (10) : 707 - 710
  • [29] Sugar-binding proteins potently inhibit dendritic cell human immunodeficiency virus type 1 (HIV-1) infection and dendritic-cell-directed HIV-1 transfer
    Turville, SG
    Vermeire, K
    Balzarini, J
    Schols, D
    JOURNAL OF VIROLOGY, 2005, 79 (21) : 13519 - 13527
  • [30] HIV-1 transmission and acute HIV-1 infection
    Hansasuta, P
    Rowland-Jones, SL
    BRITISH MEDICAL BULLETIN, 2001, 58 : 109 - 127